Products / Services
  • Products / Services
  • Companies
  • Buy Leads
Post Buy Requirement

Enzalutamide capsules

Listing ID #6529975

  • Dosage FormCapsules
  • DosageAs per Doctor's Prescription
  • StorageCool and Dry Place
  • TreatmentCancer
  • Best Before36 Months from Manufacturing
  • Supply Type Supplier
  • Preferred Buyer Location All over the world
Send Enquiry

Company Information

  • Member Since 2 Years
  • Nature of Business Exporter
  • GST No. 07ABEFM6994Q2Z7

Ask for more detail from the seller

Contact Supplier

Product Details no_img_icon

A drug used to treat prostate cancer that has spread to other parts of the body and is castration sensitive (has responded to treatments that lower testosterone levels) and prostate cancer that is castration resistant (has not responded to treatments that lower testosterone levels). It is also being studied in the treatment of other types of cancer. Enzalutamide binds to proteins called androgen receptors, which are found in some prostate cancer cells. These proteins bind to androgens (male hormones) and may cause cancer cells to grow. Enzalutamide blocks these proteins and may keep cancer cells from growing. It is a type of antiandrogen. Also called Xtandi. US Brand Name(s): Xtandi. FDA Approved Yes.

 

Enzalutamide, sold under the brand name Xtandi, is a nonsteroidal antiandrogen (NSAA) medication which is used in the treatment of prostate cancer. It is indicated for use in conjunction with castration in the treatment of metastatic castration-resistant prostate cancer (mCRPC), nonmetastatic castration-resistant prostate cancer, and metastatic castration-sensitive prostate cancer (mCSPC). It is taken by mouth.

 

Enzalutamide was first described in 2006, and was introduced for the treatment of prostate cancer in 2012. It was the first second-generation NSAA to be introduced. It is on the World Health Organization’s List of Essential Medicines.

 

Enzalutamide is approved to treat: Prostate cancer. Enzalutamide is also being studied in the treatment of other types of cancer.


Company Details close-icon

Established in 2016, Medicant Healthcare has secured a noticeable position among the Exporter and service providers of good quality Pharmaceutical Medicines and Cancer Drugs. Our drugs are designed following the FDA norms under the strict supervision of qualified experts. Our product range comprises Ulcerative Colitis, Uterus Cancer, Thyroid Cancer, Prostate Cancer, Pancreatic Cancer, Ovarian Cancer, Lung Cancer, Kidney Cancer, Gastric Cancer, Immunology, and Colorectal Cancer. Known for their fast and long-lasting results, these drugs are rather demanded around the world.

For the secure and hygienic design of the available drugs, we have established a roomy infrastructure, which is further segregated into numerous departments. The departments are capable of advanced machines, which are upgraded according to the present market demands.

A well-maintained warehouse makes sure useful storage of the offered products. According to the vast and trustworthy logistic partners, we bring our products to the customer’s end within the set time frame. Moreover, our drugs are made available at an affordable market cost.

Our revered mentors, Mr. Akhilesh Chaudhary, motivate the team with their rich industry knowledge and experience. The prime focus is on offering a smooth and pressure-free work setting for the employees and has assisted them to give their best. Additionally, they have enabled the company in gaining a strong market stand among the manufacturers and suppliers of excellent quality pharmaceutical medicines and cancer drugs.

  • Nature of Business Exporter / Service Provider / Supplier
  • Number of Employees Below 20
  • Year of Establishment 2016
Tell us your Buy Requirement to Get Instant Response
Tell us what you need?

By clicking Get Quotes Now, I accept the T&C and Privacy Policy.

Looking for enzalutamide capsules?

Quantity
Seller Contact Details
Waiting for permission
To search by voice, go to your browser settings and allow access to microphone

Allow microphone access to search with voice